When was Cadent Therapeutics founded?

Cadent Therapeutics was founded in 2017.

Where is Cadent Therapeutics headquartered?

Cadent Therapeutics is headquartered in Cambridge, Massachusetts, United States.

What industry is Cadent Therapeutics in?

Cadent Therapeutics operates in Biotech.

How many employees does Cadent Therapeutics have?

Cadent Therapeutics has 11-50 employees.

Cadent Therapeutics

Acquired

Cambridge, United States · Founded 2017

Biotech

Headquarters: Cambridge, Massachusetts
Employees: 11–50
Founded: 2017

Business Model: B2B
Website: cadenttherapeutics.com

About

Cadent Therapeutics was a Cambridge, Massachusetts-based neuroscience company that developed novel therapies targeting NMDA receptors for neurological and psychiatric conditions, including schizophrenia, movement disorders, and treatment-resistant depression. The company was founded in early 2017 through a merger of Luc Therapeutics and Ataxion, and built a pipeline of clinical-stage assets including CAD-9303 (schizophrenia, Phase 1), CAD-1883 (movement disorders, Phase 2), and MIJ821 (treatment-resistant depression). Cadent was acquired by Novartis in a deal announced December 17, 2020 and closed in Q1 2021.

Summary

Cadent Therapeutics is a Biotech company based in Cambridge, United States, founded in 2017.